Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

How do we determine which drug-induced neuroplastic changes are important?

Although many drug-induced neural changes are known, progress has been slow in identifying the ones that actually mediate addiction. Identifying changes that are specific to particular elements of the transition from initial to habitual to relapsing drug use may be a fruitful strategy for pinpointing which forms of drug-induced plasticity are critical for addiction.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Keitz, M., Martin-Soelch, C. & Leenders, K.L. Neural Plast. 10, 121–128 (2003).

    Article  CAS  Google Scholar 

  2. Wise, R.A. Nat Rev. Neurosci. 5, 483–494 (2004).

    Article  CAS  Google Scholar 

  3. Robinson, T.E. & Berridge, K.C. Annu. Rev. Psychol. 54, 25–53 (2003).

    Article  Google Scholar 

  4. Kauer, J.A. Annu. Rev. Physiol. 66, 447–475 (2004).

    Article  CAS  Google Scholar 

  5. Kelley, A.E. Neuron 44, 161–179 (2004).

    Article  CAS  Google Scholar 

  6. Jones, S. & Bonci, A. Curr. Opin. Pharmacol. 5, 20–25 (2005).

    Article  CAS  Google Scholar 

  7. Koob, G.F. et al. Neurosci. Biobehav. Rev. 27, 739–749 (2004).

    Article  CAS  Google Scholar 

  8. Nestler, E.J., Barrot, M. & Self, D.W. Proc. Natl. Acad. Sci. USA 98, 11042–11046 (2001).

    Article  CAS  Google Scholar 

  9. Mackler, S.A. et al. J. Neurosci. 20, 6210–6217 (2000).

    Article  CAS  Google Scholar 

  10. Szumlinski, K.K. et al. Neuropsychopharmacology published online 14 September 2005 (10.1038/sj.npp.1300890).

    Google Scholar 

  11. McClung, C.A. & Nestler, E.J. Nat. Neurosci. 6, 1208–1215 (2003).

    Article  CAS  Google Scholar 

  12. Carlezon, W.A., Jr. & Nestler, E.J. Trends Neurosci. 25, 610–615 (2002).

    Article  CAS  Google Scholar 

  13. Ahmed, S.H., Kenny, P.J., Koob, G.F. & Markou, A. Nat. Neurosci. 5, 625–626 (2002).

    Article  CAS  Google Scholar 

  14. Vanderschuren, L.J. & Everitt, B.J. Science 305, 1017–1019 (2004).

    Article  CAS  Google Scholar 

  15. Lu, L. et al. Nat. Neurosci. 8, 212–219 (2005).

    Article  CAS  Google Scholar 

  16. Kalivas, P.W., Volkow, N. & Seamans, J. Neuron 45, 647–650 (2005).

    Article  CAS  Google Scholar 

  17. Kalivas, P.W. & Volkow, N.D. Am. J. Psychiatry 162, 1403–1413 (2005).

    Article  Google Scholar 

  18. Baker, D.A. et al. Nat. Neurosci. 6, 743–749 (2003).

    Article  CAS  Google Scholar 

  19. Baptista, M.A., Martin-Fardon, R. & Weiss, F. J. Neurosci. 24, 4723–4727 (2004).

    Article  CAS  Google Scholar 

  20. Canales, J.J. Neurobiol. Learn. Mem. 83, 93–103 (2005).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalivas, P. How do we determine which drug-induced neuroplastic changes are important?. Nat Neurosci 8, 1440–1441 (2005). https://doi.org/10.1038/nn1105-1440

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn1105-1440

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing